Sentry is proud to announce that Lisa Scholz, PharmD, FACHE, Sentry’s Head of Industry Relations, has successfully passed the American College of Healthcare Executives (ACHE) Board of Governors Exam, earning her the prestigious Fellow of the American College of Healthcare Executives (FACHE) designation.
ACHE describes itself as “the professional society for healthcare leaders committed to improving health.” It has focused on advancing leaders in the field of healthcare management excellence for more than 85 years, and has more than 48,000 executives, including over 9,000 Fellows who, the organization says, “are committed to integrity, lifelong learning, leadership and diversity and inclusion.”
“We are extremely proud of Lisa for this impressive achievement. She is an asset to Sentry both professionally and personally, and her passion for using technology, education and advocacy to improve the quality of life for some of our country’s most disadvantaged patients exemplifies Sentry’s mission,” says Travis Leonardi, CEO and founder of Sentry Data Systems.
To earn the FACHE designation, Dr. Scholz dedicated herself to two years of study to meet the organization’s strict requirements, including continuing education and participation in several healthcare-related and community activities. As a last step, she took the Board of Governors Exam, which tested her knowledge across every major discipline in healthcare and leadership.
Dr. Scholz joined Sentry in 2015 after three years as Chief Operating Officer and SVP at 340B Health. She previously spent nearly 20 years working as a pharmacist, pharmacy operations manager and director of pharmacy in both community and hospital pharmacies and served as the vice president of the HRSA Pharmacy Services Support Center at the American Pharmacists Association.
“I have been an ACHE member since 2003. Here at Sentry, we help and influence hospital administrators daily, and I thought, what better way to truly connect with them than to share their same commitment, knowledge, and values through credentialing?” says Dr. Scholz. “I’m proud to work with hospital administrators and help foster leadership in ways that benefit the patients and communities they serve.”
A convocation ceremony will be held at the ACHE Congress Meeting on March 22, 2020 to honor Dr. Scholz and other new FACHE designees.